| 000 | 00828 a2200205 4500 | ||
|---|---|---|---|
| 005 | 20250517071724.0 | ||
| 264 | 0 | _c20151225 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a2150-0878 | ||
| 024 | 7 |
_a10.6004/jadpro.2015.6.4.6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShelledy, Lindsay | |
| 245 | 0 | 0 |
_aVemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma. _h[electronic resource] |
| 260 |
_bJournal of the advanced practitioner in oncology _c |
||
| 300 |
_a361-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 700 | 1 | _aRoman, Danielle | |
| 773 | 0 |
_tJournal of the advanced practitioner in oncology _gvol. 6 _gno. 4 _gp. 361-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.6004/jadpro.2015.6.4.6 _zAvailable from publisher's website |
| 999 |
_c25576798 _d25576798 |
||